scispace - formally typeset
T

Taghreed Hirz

Researcher at University of Texas MD Anderson Cancer Center

Publications -  16
Citations -  1082

Taghreed Hirz is an academic researcher from University of Texas MD Anderson Cancer Center. The author has contributed to research in topics: Tumor microenvironment & Cancer research. The author has an hindex of 6, co-authored 8 publications receiving 654 citations. Previous affiliations of Taghreed Hirz include University of Lyon.

Papers
More filters
Journal ArticleDOI

STK11/LKB1 Mutations and PD-1 Inhibitor Resistance in KRAS-Mutant Lung Adenocarcinoma.

Ferdinandos Skoulidis, +69 more
- 17 May 2018 - 
TL;DR: Genomic profiling may enhance the predictive utility of PD-L1 expression and tumor mutation burden and facilitate establishment of personalized combination immunotherapy approaches for genomically defined LUAC subsets.
Journal ArticleDOI

Thiazole derivatives as inhibitors of cyclooxygenases in vitro and in vivo.

TL;DR: In this study, the in vitro and in vivo effects of two novel thiazole derivatives compound 1 and compound 2 on prostaglandin E2 production and COX activity in inflammatory settings are investigated and contributes to the design of new anti-inflammatory agents and to the understanding of cyclooxygenase inhibition byThiazole.
Journal ArticleDOI

Neutrophils protect lymphoma cells against cytotoxic and targeted therapies through CD11b/ICAM-1 binding

TL;DR: Findings reveal a novel protective mechanism of neoplastic B cells involving innate immune cells which could be pharmacologically targeted to enhance the antitumor effect of therapy.
Journal ArticleDOI

Neutrophil Isolation and Analysis to Determine their Role in Lymphoma Cell Sensitivity to Therapeutic Agents.

TL;DR: The role of neutrophils on the sensitivity of lymphoma cells to anti-lymphoma agents is studied using 3-dimensional experiments using basement membrane matrix such as Matrigel to mimic the tumor microenvironment.